EF 24
Latest Information Update: 11 Sep 1996
Price :
$50 *
At a glance
- Originator Scotia Pharmaceuticals [CEASED]
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Viral infections
Most Recent Events
- 11 Sep 1996 Discontinued-II for Viral infections in Canada (Unknown route)
- 11 Sep 1996 Discontinued-II for Viral infections in France (Unknown route)
- 11 Sep 1996 Discontinued-II for Viral infections in Italy (Unknown route)